Anti-galectin-9 antibodies and uses thereof
US11629191B2 · kind B2 · utility
0Cited by
0References
17Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 28, 2022 |
| Grant date | Apr 18, 2023 |
| Priority date | — |
| Expiry date | Jun 28, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/565
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Disclosed herein are anti-Galectin-9 antibodies and methods of using such for inhibiting a signaling pathway mediated by Galectin-9 or eliminating pathologic cells expressing Galectin-9. Such anti-Galectin-9 antibodies may also be used to diagnose and/or to treat diseases associated with Galectin-9, such as autoimmune diseases and solid tumors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.